| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |